Thyrotropin suppression therapy for papillary thyroid carcinoma with a huge recurred neck lymph node
- Author:
Jung Bum CHOI
1
;
Dong-il KIM
;
Hyun-june PAIK
;
Seung Joo LEE
;
Chang Shin JUNG
;
Seok Kyung KANG
;
Youn Joo JUNG
;
Hyun Yul KIM
Author Information
- Publication Type:3
- From: Korean Journal of Clinical Oncology 2020;16(2):145-147
- CountryRepublic of Korea
- Language:English
- Abstract: Differentiated thyroid cancer (DTC) originating from thyroid tissue is affected by thyrotropin (TSH). TSH suppression therapy is usually recommended after thyroidectomy in cases of DTC. A 57-year-old woman who harbored a very huge recurred lymph node underwent TSH suppression therapy because of the risk of surgical complications. After TSH suppression, the huge neck lymph node exhibited a response and decreased in size. She had been followed up for 144 months. TSH suppression therapy could be considered as an alternative treatment option in a recurred DTC patient with a high perioperative risk.
